InflaRx N.V.
NASDAQ Global SelectTotal Valuation
InflaRx N.V. carries a market capitalization of 326.99M, placing it among publicly traded companies globally. Its enterprise value stands at 131.11M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 326.99M |
| Enterprise Value | 131.11M |
Share Statistics
InflaRx N.V. currently has 147.29M shares outstanding.
| Shares Outstanding | 147.29M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is -16,673.95, and the price-to-book ratio stands at 1.98.
| PE Ratio | N/A |
| PS Ratio | -16,673.95 |
| PB Ratio | 1.98 |
| P/TBV Ratio | 1.98 |
| P/FCF Ratio | -7.14 |
| P/OCF Ratio | -7.10 |
Enterprise Valuation
| EV / Sales | 1,681.47 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
InflaRx N.V. maintains a current ratio of 8.22, meaning it holds 8.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.57, indicating moderate leverage, while an interest coverage ratio of -590.61 demonstrates limited ability to service its debt obligations.
| Current Ratio | 8.22 |
| Quick Ratio | 7.95 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | -0.02 |
| Interest Coverage | -590.61 |
Financial Efficiency
| Return on Equity (ROE) | -38.52 |
| Return on Assets (ROA) | -32.57 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.93 |
Taxes
| Income Tax | 12,282.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
InflaRx N.V.'s stock has gained approximately 41.40127% over the past 52 weeks. The 50-day moving average sits at 2.00, while the 200-day moving average is 1.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 41.40127% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 1.50 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, InflaRx N.V. generated -10,101.00 in revenue and converted that into -39.14M in net income, yielding earnings per share of -0.46. EBITDA reached -36.17M, while operating income came in at -36.54M.
| Revenue | -10,101.00 |
| Gross Profit | -4.87M |
| Operating Income | -36.54M |
| Pretax Income | -39.08M |
| Net Income | -39.14M |
| EBITDA | -36.17M |
| EBIT | -36.54M |
| Earnings Per Share (EPS) | -0.46 |
Balance Sheet
InflaRx N.V. holds 158.51M in cash and equivalents against 833,179.00 in total debt, resulting in a net debt position of -146.57M. Total book value stands at 146.18M, with working capital of 145.27M providing operational flexibility.
| Cash & Cash Equivalents | 158.51M |
| Total Debt | 833,179.00 |
| Net Debt | -146.57M |
| Equity (Book Value) | 146.18M |
| Book Value Per Share | 0.99 |
| Working Capital | 145.27M |
Cash Flow
InflaRx N.V. produced -23.71M in operating cash flow over the past twelve months. After subtracting -135,940.00 in capital expenditures, free cash flow totaled -23.85M - equivalent to -0.28 per share.
| Operating Cash Flow | -23.71M |
| Capital Expenditures | -135,940.00 |
| Free Cash Flow | -23.85M |
| FCF Per Share | -0.28 |
Margins
InflaRx N.V. operates with a gross margin of 48,201.61, reflecting its pricing power and cost economics. The operating margin of 361,793.12 and net profit margin of 387,532.08 provide insight into operational efficiency.
| Gross Margin | 48,201.61 |
| Operating Margin | 361,793.12 |
| Pretax Margin | 386,932.13 |
| Profit Margin | 387,532.08 |
| EBITDA Margin | 358,130.66 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -43.50 |
| FCF Yield | -14.00 |
Scores
InflaRx N.V. posts an Altman Z-Score of 5.38, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.38 |